WallStreetZenWallStreetZen

NASDAQ: TNGX
Tango Therapeutics Inc Stock Ownership - Who owns Tango Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Tango Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Douglas BarryGeneral Counsel2025-02-052,556$3.16
$8.08kSell
Daniella BeckmanChief Financial Officer2025-02-053,948$3.16
$12.48kSell
Adam CrystalPresident Research Development2025-02-056,851$3.16
$21.66kSell
Barbara WeberChief Executive Officer2025-02-059,013$3.16
$28.49kSell
Adam CrystalPresident Research Development2025-02-047,432$2.99
$22.21kSell
Daniella BeckmanChief Financial Officer2025-02-044,284$2.99
$12.80kSell
Douglas BarryGeneral Counsel2025-02-042,774$2.99
$8.29kSell
Barbara WeberChief Executive Officer2025-02-049,778$2.99
$29.22kSell
Mace RothenbergDirector2024-11-1810,000$3.78
$37.80kBuy
Mace RothenbergDirector2024-11-1410,000$3.62
$36.20kBuy

1 of 5

TNGX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TNGX insiders and whales buy or sell their stock.

TNGX Shareholders

What type of owners hold Tango Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ecor1 Capital LLC22.16%23,961,472$41.69MInsider
Third Rock Ventures IV LP15.59%16,859,075$29.33MInsider
Trv GP IV LLC15.59%16,859,075$29.33MInstitution
Boxer Capital LLC14.05%15,187,092$26.43MInsider
Boxer Capital Management LLC12.65%13,679,092$23.80MInsider
Tcg Crossover Management LLC9.93%10,736,000$18.68MInstitution
Ecor1 Capital LLC9.83%10,630,736$18.50MInstitution
Boxer Capital Management LLC9.60%10,380,999$18.06MInstitution
Aaron I. Davis6.47%6,993,450$12.17MInsider
Bctg Holdings LLC6.46%6,988,450$12.16MInsider

1 of 3

TNGX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TNGX55.24%44.76%Net SellingNet Selling
FENC4.45%95.55%Net SellingNet Selling
RZLT29.07%70.93%Net BuyingNet Buying
MDWD41.09%0.00%
TARA48.50%51.50%Net SellingNet Selling
View Top Biotech Stocks

Tango Therapeutics Stock Ownership FAQ

Who owns Tango Therapeutics?

Tango Therapeutics (NASDAQ: TNGX) is owned by 98.46% institutional shareholders, 79.78% Tango Therapeutics insiders, and 0.00% retail investors. Ecor1 Capital LLC is the largest individual Tango Therapeutics shareholder, owning 23.96M shares representing 22.16% of the company. Ecor1 Capital LLC's Tango Therapeutics shares are currently valued at $39.30M.

If you're new to stock investing, here's how to buy Tango Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.